SCHEMBL3060591

SCHEMBL3060591

[S]Cc1ncccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10801303 0.79 HDAC8 (0.39)
SCHEMBL67850 0.73
SCHEMBL3030404 0.71 NAAA (0.48)
SCHEMBL7661380 0.67
SCHEMBL9948634 0.67 HSP90AA1 (0.35)
SCHEMBL13067193 0.67
SCHEMBL1016609 0.67
SCHEMBL239378 0.67
SCHEMBL2001027 0.67
SCHEMBL2420743 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222218-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-09-02 US claimed
EP-2061319-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES Bayer CropScience AG (DE) 2009-05-27 EP claimed
WO-2008019723-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2008-02-21 WO claimed
US-20100222218-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-09-02 US disclosed
EP-2092824-A1 Heterocyclyl pyrimidines Bayer CropScience AG (DE) 2009-08-26 EP disclosed
EP-2061319-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES Bayer CropScience AG (DE) 2009-05-27 EP disclosed
WO-2008019723-A1 INSECTICIDAL HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2008-02-21 WO disclosed
EP-1337534-A1 3-SUBSTITUTED 2,7-NAPHTHYRIDIN-1-YL DERIVATIVES Celltech R &amp; D Limited (GB) 2003-08-27 EP disclosed
US-6593338-B2 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells. CELLTECH R&D LIMITED (GB) 2003-07-15 US disclosed
EP-1305291-A1 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES Celltech R&amp;D Limited (GB) 2003-05-02 EP disclosed
US-20020177605-A1 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES CELLTECH R&D, LTD. (GB) 2002-11-28 US disclosed
US-6469025-B1 FOR THE PROPHYLAXIS OR TREATMENT OF A DISEASE OR DISORDER IN A MAMMAL IN WHICH THE EXTRAVASATION OF LEUKOCYTES PLAYS A ROLE; INHIBITING THE BINDING OF ALPHA 4 INTEGRINS TO THEIR LIGANDS CELLTECH R&D LTD. (GB) 2002-10-22 US disclosed
US-20020137935-A1 3-Substituted 2,7-naphthyridin-1-yl derivatives CELLTECH R&D LIMITED (GB) 2002-09-26 US disclosed
WO-2002042264-A1 3-SUBSTITUTED 2,7-NAPHTHYRIDIN-1-YL DERIVATIVES CELLTECH R & D LIMITED (GB) 2002-05-30 WO disclosed
WO-2002010136-A1 3-SUBSTITUTED ISOQUINOLIN-1-YL DERIVATIVES CELLTECH R & D LIMITED (GB) 2002-02-07 WO disclosed